Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maarten Lambert has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antibiotic Shortages: Pharmacists’ Experiences, Perspectives, and Perceived Clinical Impacts

    by Maarten Lambert, Chloé Corrie Hans Smit, Katja Taxis, Lisa Pont

    Background: Australia has experienced high rates of antibiotic shortages, yet little is known about how Australian pharmacists experience and manage them. This study aimed to explore Australian community and hospital pharmacists’ experiences of antibiotic shortages, including their perceived clinical impact and approaches to managing shortages. Methods: An exploratory qualitative study using semi-structured interviews was conducted with Australian community and hospital pharmacists between May and August 2024. Participants were recruited via convenience sampling through professional networks and social media. Interviews were audio-recorded, transcribed verbatim, and analysed thematically using an inductive–deductive approach, with coding performed independently by two researchers. Results: Fifteen interviews were conducted before data saturation was reached. Sixty percent of participants were female, 67% worked in hospital settings, and pharmacists were located across five Australian states. Four overarching themes were identified: factors driving shortages, communication and collaboration, impact of shortages, and mitigation and prevention. Pharmacists described antibiotic shortages as frequent and unpredictable, attributing them to supply-chain vulnerabilities, limited manufacturing, and market competition. Shortages were reported to affect treatment choice, contribute to antimicrobial resistance concerns, increase pharmacist workload and stress, and negatively affect patients. Pharmacists used strategies such as stock management, collaboration, and importing alternatives, but felt that lasting solutions required coordinated national action. Conclusions: Australian pharmacists perceive antibiotic shortages as a complex challenge affecting patient care, antimicrobial stewardship, workload, and healthcare efficiency. While pharmacists have developed reactive strategies to manage shortages, stronger communication, collaboration, and national policy coordination, alongside improved supply-chain resilience, are needed to reduce the impact of future shortages.


  • Open Access

    Estimating cost savings from reducing antibiotic overprescription in european general practices

    by Fabiana Raynal Floriano, Laura Vallejo-Torres, Marina Elistratova, Beatriz González López-Valcárcel, Ana García-Sangenís, Jesper Lykkegaard, Malene Plejdrup Hansen, Lars Bjerrum, Athina Chalkidou, Jette Nygaard Jensen, et al.

    Background: Antibiotic (ATB) overprescription leads to antimicrobial resistance (AMR) and adverse events (AEs) and poses significant economic burdens on European healthcare systems. The aim of this study was to assess the economic impact associated with interventions aimed at reducing unnecessary ATB prescriptions in general practice, and to extrapolate the results at the European Union (EU) level. Methods: We used data from the “HAPPY PATIENT” project, a before-and-after study that implemented a multifaceted intervention in primary care settings in France, Greece, Lithuania, Poland, and Spain. Based on the outcomes observed in general practice across these five countries we extrapolated the results to estimate for each of the 27 EU member states: i) the costs of implementing the interventions, ii) the number of potentially unnecessary ATB prescriptions avoided, and iii) the potential savings due to reductions in unnecessary ATB prescriptions. We considered a realistic and an optimistic scenario: using the mean and the largest reduction in unnecessary ATB prescriptions observed across each of the five participating countries, respectively. Results: Across the EU, €2.7 billion are estimated to be spent annually on healthcare resources linked to potentially unnecessary ATB prescribed in general practice. Implementing the interventions across the EU is projected to cost €107 million. Positive net savings were estimated in both scenarios, €151 million in the realistic scenario and €423 million in the optimistic scenario. Several sensitivity analyses were conducted to characterise the substantial uncertainty surrounding these estimates, which yielded considerable potential savings in all cases.


  • Open Access

    Second audit of the Happy Patient project: impact of training on the dispensing of antibiotics in community pharmacies in Spain

    by Francisco Javier Plaza Zamora, Ana Mendoza Barbero, Ana Molinero, Navidad Sánchez Marcos, Maarten Lambert, Katja Taxis, Ana García-Sangenis, Carles Llor

    Antibiotic resistance is a major public health problem. The European Happy Patient project aims to optimize antimicrobial use through audits and training of healthcare professionals, including community pharmacists. Objectives: To evaluate the impact of an educational intervention on the quality of antibiotic dispensing in Spanish community pharmacies and to identify areas for improvement following the training. A five-hour multifactorial intervention was conducted at IDIAP Jordi Gol (Barcelona) in January 2023, including feedback on results, communication workshops, and educational materials. Subse-quently, a second audit (February–April 2023) was carried out using the Audit Project Odense® method in 16 community pharmacies. A total of 450 dispensations of oral antibiotics for acute infections were analyzed. Sixty percent of patients were women, and 90% were aware of the indication for the antibiotic. Relevant increases were observed in safety checks: drug interactions (+26%), contraindications (+23%), and allergies (+20%), with all three being performed in 60% of cases. Personalized information provided to patients increased regarding treatment duration (66%à80%), antimicrobial resistance (30%à48%), and medicine return/disposal (6%à28%). Contact with the prescriber increased from 0.9% to 9.3%. The educational intervention significantly improved the quality of antibiotic dispensing by increasing patient counseling and safety checks. These results support the implementation of ongoing training programs that strengthen the clinical role of community pharmacists in the rational use of antibiotics and the fight against antimicrobial resistance.

  • Open Access

    Reducing antibiotic exposure to combat antimicrobial resistance: rethinking use, packaging, and dispensing practices

    by Maarten Lambert, Saleh Aljadeeah, Nosheen Nasir, Faith Sila, Luciane Lopes, Carl Llor


  • Open Access

    Lessons from the field: implementing pharmacy services in the Tanzanian hospital setting

    by Maarten Lambert, John Mmassy, Sungwa Kabissi, Cecilia Benizeth, Gasper Baltazary, Betty Allen Maganda, Katja Taxis


  • Open Access

    Adherence to antibiotic prescribing guidelines in Dutch primary care: an analysis of national prescription data on ear and respiratory tract symptoms and conditions among 384 general practices

    by Maarten Lambert, Renee Veldkamp, Yvette Weesie, Anke Lambooij, Jochen W L Cals, Katja Taxis, Liset van Dijk, Karin Hek

    Background: Mapping general practitioners’ antibiotic prescribing practices is essential to optimize antibiotic use in primary care and mitigate antibiotic resistance. Objectives: The objective of this study was to examine the adherence of Dutch general practitioners to prescribing guidelines for ear and respiratory tract symptoms and conditions. Methods: A cross-sectional study was conducted on Dutch electronic health records from 2018 to 2021. Antibiotic prescribing frequency and type were examined for ear and respiratory tract symptoms and conditions based on professional prescribing guidelines. Descriptive statistics and multilevel logistic regression analyses were applied. Results: Patient records from up to 384 general practices were analysed for 15 ear and 27 respiratory tract conditions. For 11 of the 15 (73%) ear and 17 of the 27 (63%) respiratory tract conditions, more than 95% of patients were treated according to the prescribing guidelines. Most potential non-adherence to antibiotic prescribing guidelines occurred for acute otitis media (31%–34%), acute bronchitis/bronchiolitis (26%–39%), and acute sinusitis (25%–34%). Several other respiratory tract conditions showed non-indicated prescribing rates above 10%. For otitis externa, many broad-spectrum antibiotics were prescribed, which rarely happened for respiratory conditions. High variation in prescribing frequency and type between general practices occurred. Conclusions: For most conditions, Dutch general practitioners adhere well to antibiotic prescribing guidelines. There are conditions for which there is a high potential for inappropriate prescribing. High variation between practices suggests room for improvement. Stricter implementation of prescribing guidelines may help improve prescribing practice. Alternatively, a practice-specific approach could be effective. The Dutch setting may be exemplary for international antibiotic prescribing practice.


  • Open Access

    Community pharmacists’ role in optimising antibiotic use: The HAPPY PATIENT project to improve dispensing practices in five EU countries

    by Maarten Lambert, Ria Benko, Jesper Lykkegaard, Jens Søndergaard, Jonas Olsen, Ana Garcia-Sangenis, Marilena Anastasaki, Christos Lionis, Malene Plejdrup Hansen, Pia Touboul Lundgren, et al.


  • Open Access

    Impact of Antibiotic Shortages on Antibiotic Utilisation in the Community

    by Maarten Lambert, Katja Taxis, Lisa Pont

    Background: Drug shortages are an increasing and worldwide problem. Oral antibiotics are one of the most used medicines worldwide and have recently been affected by drug shortages. Despite this, little is known about the impact of antibiotic shortages on prescribing practices.Aim: To explore the impact of oral antibiotic shortages on national antibiotic utilisation.Methods: A cross‐sectional study of oral antibiotic shortages and antibiotic utilisation was conducted using Australian reimbursement and regulatory data from January 2022 to December 2023. All nationally reimbursed oral antibiotics were included in the study. The number and duration of reported antibiotic shortages per product were determined for each active ingredient. The clinical impact was assessed using national utilisation in Defined Daily Doses per 100 000 inhabitants. Changes in trends were analysed using Joinpoint regression.Results: Shortages were reported for eighteen of the twenty‐one (86%) oral antibiotics reimbursed in Australia. For ten active ingredients, shortages did not coincide with changes in utilisation data. No clear relation between the number and duration of shortages and impact on utilisation was observed. Changes in utilisation coinciding with shortages were observed for eight active ingredients. For cefaclor (−20% decrease in utilisation) and roxithromycin (−26% decrease), the impact of shortages is most clearly reflected by decreases in utilisation. For the other six, minor changes in utilisation were observed coinciding with shortages.Conclusions: Antibiotic shortages were common in Australia during 2022 and 2023. The impact of shortages differs per antibiotic, for some antibiotics there are shortages coinciding with declines in utilisation. For others, shortages occur without apparent changes in utilisation.


  • Open Access

    Impact of a multifaceted intervention programme on antibiotic prescribing and dispensing in four patient-centred settings in five European countries. The HAPPY PATIENT project

    by Ana García-Sangenís, Jesper Lykkegaard, Malene Plejdrup Hansen, Beatriz González López-Valcárcel, Fabiana Raynal, Laura Vallejo-Torres, Lars Bjerrum, Athina Chalkidou, Jette Nygaard Jensen, Ingrid Rebnord, et al.

    Background: The primary cause of antimicrobial resistance is excessive and non-indicated antibiotic use. Aim: To evaluate the impact of a multifaceted intervention aimed at various healthcare professionals (HCPs) on antibiotic prescribing and dispensing for common infections. Design and setting: Before-and-after study set in general practice, out-of-hours services, nursing homes, and community pharmacies in France, Greece, Lithuania, Poland, and Spain. Methods: Following the Audit Project Odense method, HCPs from these four settings self-registered encounters with patients related to antibiotic prescribing and dispensing before and after an intervention (February–April 2022 and February–April 2023). Prior to the second registration, the HCPs undertook a multifaceted intervention, which included reviewing and discussing feedback on the first registration’s results, enhancing communication skills, and providing communication tools. Indicators to identify potentially unnecessary prescriptions and non-first-line antibiotic choices were developed, and the results of the two registrations were compared. Results: A total of 345 HCPs registered 10 744 infections in the first registration period and 10 207 infections in the second period. In general practice, participants showed a significant 9.8% reduction in unnecessary antibiotic prescriptions in the second period, whereas limited or no effect was observed in out-of-hours services and nursing homes (0.8% reduction and 4.5% increase, respectively). Pharmacies demonstrated an 18% increase in safety checks, and correct advice in pharmacies rose by 17%. Conclusion: External factors like COVID-19, antibiotic shortages, and a streptococcal epidemic impacted the intervention’s benefits. Despite this, the intervention successfully improved antibiotic use in both settings.


  • Open Access

    Impact of Antibiotic Shortages on Antibiotic Utilisation in the Community

    by Maarten Lambert, Katja Taxis, Lisa Pont

    Background. Drug shortages are an increasing and worldwide problem. Oral antibiotics are one of the most used medicines worldwide and have recently been affected by drug shortages. Despite this, little is known about the impact of antibiotic shortages on clinical and prescribing practices. Aim. To explore the impact of oral antibiotic shortages on national antibiotic utilisation. Methods. A longitudinal study of oral antibiotic shortages and antibiotic utilisation was conducted using Australian reimbursement and regulatory data from January 2022 to December 2023. All nationally reimbursed oral antibiotics were included in the study. The number and duration of reported antibiotic shortages per product were determined for each active ingredient. The clinical impact was assessed using national utilisation in Defined Daily Doses per 100,000 inhabitants. Changes in trends were analysed using Joinpoint regression. Results. Shortages were reported for eighteen of the twenty-one (86%) oral antibiotics reimbursed in Australia. No clear relation between the number and duration of shortages was observed for most antibiotics. Changes in utilisation coinciding with shortages were observed for eight active ingredients. For cefaclor (-20% decrease in utilisation) and roxithromycin (-26% decrease), the impact of shortages is most clearly reflected by decreases in utilisation. For the other six, either minor or mixed changes in utilisation were observed. Conclusions. Antibiotic shortages were common in Australia during 2022 and 2023. The impact of shortages appears complex with various factors most likely influencing impact. Australia’s healthcare professionals seem successful in mitigating the effects of shortages on drug utilisation.